Literature DB >> 15591321

Transmembrane domain helix packing stabilizes integrin alphaIIbbeta3 in the low affinity state.

Anthony W Partridge1, Shouchun Liu, Sanguk Kim, James U Bowie, Mark H Ginsberg.   

Abstract

Regulated changes in the affinity of integrin adhesion receptors ("activation") play an important role in numerous biological functions including hemostasis, the immune response, and cell migration. Physiological integrin activation is the result of conformational changes in the extracellular domain initiated by the binding of cytoplasmic proteins to integrin cytoplasmic domains. The conformational changes in the extracellular domain are likely caused by disruption of intersubunit interactions between the alpha and beta transmembrane (TM) and cytoplasmic domains. Here, we reasoned that mutation of residues contributing to alpha/beta interactions that stabilize the low affinity state should lead to integrin activation. Thus, we subjected the entire intracellular domain of the beta3 integrin subunit to unbiased random mutagenesis and selected it for activated mutants. 25 unique activating mutations were identified in the TM and membrane-proximal cytoplasmic domain. In contrast, no activating mutations were identified in the more distal cytoplasmic tail, suggesting that this region is dispensable for the maintenance of the inactive state. Among the 13 novel TM domain mutations that lead to integrin activation were several informative point mutations that, in combination with computational modeling, suggested the existence of a specific TM helix-helix packing interface that maintains the low affinity state. The interactions predicted by the model were used to identify additional activating mutations in both the alpha and beta TM domains. Therefore, we propose that helical packing of the alpha and beta TM domains forms a clasp that regulates integrin activation.

Mesh:

Substances:

Year:  2004        PMID: 15591321     DOI: 10.1074/jbc.M412701200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  65 in total

1.  Tests of integrin transmembrane domain homo-oligomerization during integrin ligand binding and signaling.

Authors:  Wei Wang; Jieqing Zhu; Timothy A Springer; Bing-Hao Luo
Journal:  J Biol Chem       Date:  2010-11-16       Impact factor: 5.157

Review 2.  Integrins as therapeutic targets: lessons and opportunities.

Authors:  Dermot Cox; Marian Brennan; Niamh Moran
Journal:  Nat Rev Drug Discov       Date:  2010-10       Impact factor: 84.694

3.  The NPIY motif in the integrin beta1 tail dictates the requirement for talin-1 in outside-in signaling.

Authors:  Bethsaida Nieves; Christopher W Jones; Rachel Ward; Yasutaka Ohta; Carlos G Reverte; Susan E LaFlamme
Journal:  J Cell Sci       Date:  2010-03-23       Impact factor: 5.285

Review 4.  Structure and function of the platelet integrin alphaIIbbeta3.

Authors:  Joel S Bennett
Journal:  J Clin Invest       Date:  2005-12       Impact factor: 14.808

Review 5.  Integrin structures and conformational signaling.

Authors:  Bing-Hao Luo; Timothy A Springer
Journal:  Curr Opin Cell Biol       Date:  2006-08-14       Impact factor: 8.382

Review 6.  Structural basis of integrin regulation and signaling.

Authors:  Bing-Hao Luo; Christopher V Carman; Timothy A Springer
Journal:  Annu Rev Immunol       Date:  2007       Impact factor: 28.527

7.  Tests of the extension and deadbolt models of integrin activation.

Authors:  Jieqing Zhu; Brian Boylan; Bing-Hao Luo; Peter J Newman; Timothy A Springer
Journal:  J Biol Chem       Date:  2007-02-13       Impact factor: 5.157

8.  Identification of integrin beta subunit mutations that alter affinity for extracellular matrix ligand.

Authors:  Timmy Kendall; Leona Mukai; Alison L Jannuzi; Thomas A Bunch
Journal:  J Biol Chem       Date:  2011-07-11       Impact factor: 5.157

9.  Migfilin, a molecular switch in regulation of integrin activation.

Authors:  Sujay Subbayya Ithychanda; Mitali Das; Yan-Qing Ma; Keyang Ding; Xiaoxia Wang; Sudhiranjan Gupta; Chuanyue Wu; Edward F Plow; Jun Qin
Journal:  J Biol Chem       Date:  2008-12-13       Impact factor: 5.157

10.  L718P mutation in the membrane-proximal cytoplasmic tail of beta 3 promotes abnormal alpha IIb beta 3 clustering and lipid microdomain coalescence, and associates with a thrombasthenia-like phenotype.

Authors:  Asier Jayo; Isabel Conde; Pedro Lastres; Constantino Martínez; José Rivera; Vicente Vicente; Consuelo González-Manchón
Journal:  Haematologica       Date:  2010-01-15       Impact factor: 9.941

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.